Today's Healthcare Pulse
FDA greenlights durvalumab combo for high‑risk bladder cancer
The FDA approved durvalumab (Imfinzi) combined with Bacillus Calmette‑Guerin for BCG‑naïve, high‑risk non‑muscle invasive bladder cancer. The POTOMAC trial enrolled 1,018 patients and showed a 32% reduction in disease recurrence risk (hazard ratio 0.68, p=0.015). Durvalumab is given at 1,500 mg IV every four weeks for up to 13 cycles.
Also developing:
By the numbers: Apogee Therapeutics raises $1.3B royalty financing
Will ACCESS Move the Needle on Tech-Enabled Chronic Care?
The Centers for Medicare & Medicaid Services (CMS) will launch the Advancing Chronic Care with Effective, Scalable Solutions (ACCESS) model on July 5, 2026, a ten‑year voluntary payment experiment for fee‑for‑service Medicare beneficiaries with hypertension, diabetes, chronic musculoskeletal pain or depression. The model introduces Outcome‑Aligned Payments, offering $180‑$360 per beneficiary in the first year and $90‑$210 for follow‑on care, contingent on meeting an Outcome Attainment Threshold of 50% after 12 months. Digital health firms such as Withings and Brook Health welcome the initiative, citing alignment with consumer demand for home‑based monitoring, while some warn that the modest rates may not cover clinician costs. Success will hinge on providers’ ability to deliver measurable health improvements under the new financial constraints.
School Nurses Report Satisfaction with Stock Inhaler Program
The Resources for Every School Confronting Unexpected Emergencies Illinois (RESCUE‑IL) stock inhaler program was evaluated across 483 Illinois public schools, with 327 nurses and staff responding. Satisfaction was high, with 96.3% reporting they were very satisfied or satisfied, and 95.9%...
NPHI Calls for National Moratorium on New Provider Medicare Enrollment
The National Partnership for Healthcare & Hospice Innovation (NPHI) has urged the Centers for Medicare & Medicaid Services (CMS) to impose a temporary, nationwide moratorium on new hospice provider enrollments, citing a rise in fraudulent operators. The organization’s letter also...
US FDA Approves Higher-Dose of Biogen’s Genetic Disorder Drug
The U.S. FDA has approved a higher‑dose version of Biogen’s gene‑replacement therapy for a rare genetic muscle‑weakening disorder, likely spinal muscular atrophy. The new regimen starts with two 50 mg loading doses two weeks apart, followed by a 28 mg maintenance dose...
Why Americans Aren't Living Longer
Tufts University researchers found that U.S. life expectancy improvements have stalled over the last decade, with baby‑boomers (born 1950‑59) and the 1970‑85 cohort experiencing lower longevity than their predecessors. The study links the slowdown primarily to rising mortality from cardiovascular...
Homeless Populations in Need of Stronger Hospice Support
Morning Light Inc., an Indiana nonprofit, is tackling the hospice gap for aging homeless individuals by providing free housing alongside end‑of‑life care. In 2023 the organization cared for 51 hospice patients, averaging 58 days per stay, within its 12‑room facility....
Dr Robert Malone Quits the CDC, Says There May Be a MOLE Inside the Agency
Dr. Robert Malone resigned from the CDC’s vaccine advisory committee, alleging the agency is plagued by internal sabotage and constant bickering. He claims a "mole"—appointed by Robert F. Kennedy Jr.—is embedded within the CDC to undermine vaccine policy. Malone speculates...
When There’s No Place for Silence in Science: A Personal Disclosure
Katie Schenk, a veteran public‑health epidemiologist, publicly disclosed that she recently resigned from the CDC after years of keeping her federal role hidden. She explains that growing political pressure and a widening gap between scientific evidence and agency decisions made...
CVS Begins Rollout Of Smaller ‘Pharmacy-Only’ Stores
CVS Health announced the launch of its first pharmacy‑only store in Chicago and plans to open nearly 20 similar locations by year‑end. The new format, about 3,000 square feet, focuses on prescription fulfillment, vaccinations and a curated OTC assortment, cutting...
Hiring Top Doctors to Ensure Quality Patient Care
As MYRESET prepares for launch in early April — my co founder and I have had the pleasure of speaking to so many competent doctors. We’re taking only the best for our team, both in skills and personality to ensure...
India Rolls Out Evidence‑Based Yoga Protocols to Tackle Lifestyle Diseases
India's Union Ministry of Ayush has launched a nationwide, evidence‑based Yoga Protocol for Non‑Communicable Diseases, targeting diabetes, hypertension, asthma and mental health. The initiative, unveiled at Yoga Mahotsav 2026, seeks to shift the health system from treatment to prevention.
China Breaks World Record with 35.6‑Tesla Fully Superconducting Magnet
Researchers from the Chinese Academy of Sciences have built a fully superconducting user magnet that reached 35.6 tesla, shattering the previous 32.0‑tesla record. The breakthrough, demonstrated on Jan. 23, 2026, promises unprecedented magnetic‑field capability for high‑field science, nuclear‑fusion experiments and next‑generation...
Meta‑Analysis Finds Collagen Supplements Boost Skin, Joint and Muscle Health
A comprehensive 2026 meta‑analysis of 113 clinical trials and nearly 8,000 participants concludes that hydrolysed collagen supplements produce moderate improvements in muscle health, lessen osteoarthritis pain, and enhance skin elasticity and hydration. The findings revive scientific and consumer interest in...
A Novel G9a Inhibitor Reduces Symptoms in Mouse Models of Alzheimer's Disease
Researchers have unveiled FLAV-27, a novel G9a histone methyltransferase inhibitor that readily crosses the blood‑brain barrier and exhibits subnanomolar potency. The compound demonstrates high selectivity for G9a over related enzymes and a favorable safety profile, addressing the limitations of earlier...
SLIT3 Protein Identified as Boost for Brown-Fat Calorie Burning, Opening New Biohacking Path
Researchers analyzing more than 15,000 human fat samples have identified the SLIT3 protein as a potent enhancer of brown‑fat calorie burning. The discovery suggests a novel, metabolism‑focused avenue for obesity treatment and biohacking beyond appetite‑suppressing drugs.
First-in-Human Hepatitis D Antibody Administered in Beijing Amid Mixed Pharma Outlook
A Chinese biotech company administered the first-in-human dose of a hepatitis D‑targeted monoclonal antibody in Beijing, marking a world‑first for the disease. The trial details were not disclosed, and it comes as the broader pharma sector grapples with earnings pressure,...
Microneedle Patch Enables Real‑Time Immune Monitoring, Could Replace Blood Draws
Researchers at The Jackson Laboratory and MIT unveiled a polymer‑based microneedle skin patch that captures immune cells and inflammatory biomarkers within 15‑30 minutes. The device could transform vaccine response tracking and chronic disease monitoring by eliminating the need for blood...
States Award $45.6 M to Deloitte, Accenture, Optum to Enforce One Big Beautiful Bill Act
State governments have signed contracts worth at least $45.6 million with consulting firms Deloitte, Accenture and Optum to re‑engineer eligibility systems under the One Big Beautiful Bill Act. The changes are expected to push 7.5 million people off Medicaid by 2034 and...
AstraZeneca’s Tozorakimab Cuts COPD Flare‑Ups, Shares Jump 3.8%
AstraZeneca announced that its experimental monoclonal antibody tozorakimab met primary endpoints in two late‑stage COPD trials, delivering a clinically meaningful reduction in moderate‑to‑severe flare‑ups. The data lifted the company’s shares as much as 3.8% and underpin a sales outlook of...
Eli Lilly Signs $2.75 B AI Drug Deal with Insilico Medicine, $115 M Upfront
Eli Lilly and Hong Kong‑listed Insilico Medicine have sealed a partnership that could be worth up to $2.75 billion, including a $115 million upfront payment. The deal gives Lilly exclusive global rights to Insilico’s pre‑clinical oral candidates and taps the biotech’s generative‑AI platform....
KAIST Study Shows Graphene Oxide Kills Bacteria While Sparing Human Cells
Researchers at South Korea's KAIST have demonstrated that graphene oxide can selectively eradicate bacterial cells while leaving human cells intact. The finding points to a new class of nanomaterial‑based antibiotics that could help combat the growing threat of antimicrobial resistance.
Setting Goals Beyond Weight at the OC Summit
At the Obesity Canada Summit, clinicians, patients, and advocates argued that obesity care should target health outcomes beyond weight loss. A new paper in *Diabetes, Obesity, and Metabolism* proposes a co‑design framework that integrates cardiometabolic risk, physical function, quality‑of‑life, and...
Q&A: Digital Workforce Looks to Expand Further Into the U.S. Market
Digital Workforce, a Helsinki‑based automation firm, serves over 200 large organizations and targets roughly $40 million in revenue this year. Its flagship Outsmart platform blends robotic process automation and AI to run entire patient‑care pathways, with a particular emphasis on healthcare...
Study: Breath Test Could Transform Microbiome Diagnostics for Clinical Labs
Researchers at Washington University School of Medicine and Children’s Hospital of Philadelphia have demonstrated that volatile organic compounds (VOCs) in exhaled breath mirror gut microbiome activity. Published in Cell Metabolism, the proof‑of‑concept study showed breath profiles could differentiate children with...
Medtronic Wins FDA Clearance for Robot in Cranial, ENT Surgeries
Medtronic has secured FDA 510(k) clearance for its Stealth AXiS surgical system, extending its use to cranial and ear‑nose‑throat (ENT) procedures. The modular platform combines AI‑enabled tractography, navigation and real‑time ultrasound, and can operate in both hospitals and ambulatory surgery centers....
5 Takeaways From The Newly Released Brain & Heart Guidelines
The 2026 C‑CHANGE/CMAJ clinical guidelines formally unite brain and heart health, presenting 11 harmonized recommendations. They now require routine cognitive screening for atrial fibrillation patients and depression screening for coronary artery disease sufferers. Intensive blood‑pressure control is endorsed for its...
GXO Appointed to Support NHS England Bowel Cancer Screening
GXO Logistics has been selected by NHS England to manage the supply and distribution of home testing kits for the national bowel cancer screening programme, specifically the Faecal Immunochemical Test (FIT). The logistics firm will act as a managed service...
From Burnout to Breakthrough: How Healthcare Organizations Are Finally Reducing Administrative Burden
Healthcare organizations are confronting a hidden driver of clinician burnout: the massive administrative workload tied to documentation, referrals, lab results and prior authorizations. Despite widespread electronic health record adoption, billions of fax pages and manual data entry still dominate daily...
Beyond Accuracy: What “Defensible Coding” Really Means Under Today’s RADV Scrutiny
The article warns that risk‑adjustment compliance has moved beyond mere coding accuracy to require defensible, clinically‑grounded processes. Auditors now flag plans that only add codes without deletions, seeing a revenue‑driven pattern rather than true clinical documentation. AI explainability alone is...
Choosing an Analytic Approach
The RAND‑posted paper offers a systematic framework for choosing analytic methods in state‑policy evaluations, emphasizing how study setting and data availability shape design choices. It outlines key considerations such as control group definition, policy timing, effect heterogeneity, and data structure....
Understanding and Managing Tooth Discoloration: Safe At-Home Whitening Methods
A 2023 American Dental Association survey shows nearly 80% of adults are dissatisfied with their tooth color, yet only 15% seek professional whitening, fueling a surge in at‑home solutions. Professional treatments cost $300‑800 per session, while over‑the‑counter strips, gels, and...
Pharma Pulse: A Call for U.K. Pricing Reform and the Latest FDA-Approved Biosimilar for Bone Health
Eli Lilly is urging the United Kingdom to overhaul its drug‑pricing framework, warning that persistently low prices could deter future investment and calling for outcomes‑based reimbursement models, especially for obesity therapies. At the same time, the U.S. Food and Drug Administration...
STAT+: Health Care Jobs Growth Is Stagnating at the Biggest For-Profit Firms
STAT’s analysis of the 50 largest publicly traded health‑care firms shows that job growth at these for‑profit giants has stalled over the past five years, even as the broader health‑care sector continues to expand the U.S. labor market. Health insurers...
Something of a Shopping Spree: Novartis to Acquire US-Based Excellergy for up to $2bn
Novartis announced a deal to acquire California‑based Excellergy for up to $2 bn, securing the Phase I antibody Exl‑111 that targets both free and cell‑bound IgE. The acquisition bolsters Novartis’ allergy pipeline, positioning the drug as a next‑generation complement to its existing...
Allergan Aesthetics Highlights Undetectable Era for HA Injectables
Allergan Aesthetics, an AbbVie subsidiary, announced the "undetectable era" for hyaluronic acid (HA) injectables at the Aesthetic & Anti-Aging Medicine World Congress 2026 in Monaco. The company unveiled its global research study, "Layered Beauty: The New Aesthetic Mindset," which highlights...
Doctors Must Choose: Silence or Educate Online
Doctors, what’s your view on doctors creating content? Is it unprofessional? Or necessary? Patients are already consuming health content. The question is — from whom? Less qualified voices are louder. Algorithms don’t reward silence. Does sharing knowledge dilute dignity? Or strengthen trust? Is content ego-driven? Or patient education? Medicine is evolving. Communication...
Insilico, Tenacia Expand AI-Driven CNS Collaboration
Insilico Medicine and Tenacia Biotechnology have broadened their AI‑driven collaboration to create additional small‑molecule therapies for central nervous system disorders. Building on a March 2025 program that combined Insilico’s Pharma.AI platform with Tenacia’s proprietary data, the partners will use generative...
New AI Research Reshapes Neuroprotective Drug Discovery Funding
BCC Research’s new Pulse report, “AI Impact on Neuroprotective Agents,” outlines how artificial intelligence is reshaping the discovery, development, and delivery of neuroprotective therapies. The study projects a 4.5% CAGR for the North American market through 2030 and documents hundreds...
Bioventix SMA Adopted by Top IVD and Research Platforms
Positive update from Bioventix, confirming its position as a key player in the emerging Neurology & Alzheimer’s blood-testing market. “Amongst the RuO B-D pT217 assays being developed by the leading IVD companies (e.g. Roche, Siemens, Abbott, Beckman, Quidel-Ortho, Mindray etc.),...
Scalable Biotech Manufacturing Targets $14B Cell Therapy Market
Research forecasts the global cell‑therapy manufacturing market to exceed $7 billion in 2026 and reach $14 billion by 2035. The FDA has introduced new manufacturing flexibility to accelerate approval timelines for cell and gene therapies, addressing a capacity bottleneck that analysts expect...
ADHD Medication in Short Supply in Japan as Demand Soars
Japan is experiencing a nationwide shortage of Concerta, the primary stimulant used to treat adult ADHD, as demand surges. The shortage, first noted in late 2023, persists despite Janssen Pharmaceutical’s promise of a two‑month fix, with officials now estimating several...
The Future of Sex as a Biological Variable in Health Research
On Jan. 20, 2025 President Donald Trump signed an executive order that recognizes only two sexes and mandates federal agencies use the term “sex” instead of “gender.” The order abruptly removed the NIH Sex as a Biological Variable (SABV) policy webpages, unsettling...
Monday Briefing: Has the Single-Use Vape Ban Made Any Difference to Our Health or Our Environment?
Nearly a year after the UK outlawed single‑use disposable vapes, new data show only modest health and environmental gains. Vaping prevalence remains at 5.4 million adults, with no clear reduction in smoking‑related illnesses. Waste audits indicate a roughly 15 percent drop in...
Europe’s Pivotal Choice: Vaccination Is Health Security
Europe is positioning vaccination as a strategic asset, linking political will, science, and capital to secure health and economic resilience. The European Commission has pledged €225 million to fast‑track next‑generation flu vaccines, including the NOFLU consortium’s mRNA mucosal candidate. By integrating...
10 European Startups to Watch in 2026
A curated list of ten European biotech startups founded since 2021 showcases rapid progress toward clinical milestones and sizable financing. Companies such as Isomorphic Labs, Draig Therapeutics and Adcytherix are moving from platform development to first‑in‑human trials, backed by funding...
Strong for Life Part 2 – From Frailty Score to Strength Prescription
Strength training is positioned as a modifiable lever to counter frailty, using the Rockwood Clinical Frailty Scale (CFS) to tailor exercise intensity. The article outlines a three‑level prescription matrix—supported, standard, and power—matched to CFS bands, recommending 4‑6 core movements performed...
The Gut Health Episode: Harvard Doctor Reveals What’s Normal (and What’s Not)
In this episode, Mel Robbins talks with Harvard neurogastroenterologist Dr. Tricia Pasricha about the gut‑brain connection, demystifying what’s normal and abnormal when it comes to digestion, bloating, constipation, and pooping. Dr. Pasricha explains that the gut functions like a second...
Malnourished Children and Desperate Mothers: The Healthcare Facility on the Frontline of Nigeria’s Hunger Crisis
A frontline health centre in Kaita, Katsina state, run by the Alliance for International Medical Action (Alima), is treating thousands of children suffering acute malnutrition as Nigeria’s hunger crisis deepens. The Red Cross warns up to 33 million Nigerians could face...
FDA Launches New AI-Powered System to Track Drug and Vaccine Side Effects
The FDA launched the AI‑powered Adverse Event Monitoring System (AEMS) on March 11, 2026, consolidating VAERS, FAERS and other databases into a single, real‑time platform. AI automates data entry and categorization, replacing quarterly updates with instant reporting. Early testing showed...
Postpartum Mental Health Training Missing From U.S. Counseling Curricula
It is a systemic failure of massive proportions that a class on postpartum mental health is not a requirement for graduation for every counseling, therapy, and clinical social work program in America.